How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?

1995 ◽  
Vol 1 (6) ◽  
pp. 435-443 ◽  
Author(s):  
Joseph M. Pilewski ◽  
Raymond A. Frizzell
2012 ◽  
Vol 302 (11) ◽  
pp. L1141-L1146 ◽  
Author(s):  
James F. Collawn ◽  
Ahmed Lazrak ◽  
Zsuzsa Bebok ◽  
Sadis Matalon

Cystic fibrosis (CF) is caused by the loss of the cystic fibrosis transmembrane conductance regulator (CFTR) function and results in a respiratory phenotype that is characterized by dehydrated mucus and bacterial infections that affect CF patients throughout their lives. Much of the morbidity and mortality in CF results from a failure to clear bacteria from the lungs. What causes the defect in the bacterial clearance in the CF lung has been the subject of an ongoing debate. Here we discuss the arguments for and against the role of the epithelial sodium channel, ENaC, in the development of CF lung disease.


PLoS ONE ◽  
2012 ◽  
Vol 7 (6) ◽  
pp. e39809 ◽  
Author(s):  
Peter A. Sloane ◽  
Suresh Shastry ◽  
Andrew Wilhelm ◽  
Clifford Courville ◽  
Li Ping Tang ◽  
...  

2019 ◽  
Vol 7 (30) ◽  
pp. 43-46
Author(s):  
Jonathan Kopel

Cystic fibrosis (CF) remains a prevalent genetically inherited disease in Caucasianpopulations. Investigation of the respiratory symptoms which occur in patients with CF helps usunderstand the pathophysiology of chronic lung disease. Environmental insults, such as cigarettesmoke, can reduce the cystic fibrosis transmembrane receptor (CFTR) function or expressionleading to an acquired CF phenotype and could contribute to the development and progressionof smoking-related lung disease. However, it is uncertain if the acquired CF phenotype can bediagnosed with the same methods, such as the sweat chloride test and the measurementof nasal potential difference, used for genetically-acquired CF. More studies are needed toinvestigate the prevalence of acquired CFTR dysfunction and the differences between acquiredand genetically-inherited CFTR dysfunction. Overall, acquired CFTR dysfunction challengesthe distinction between genetic and acquired disorders, suggesting that environmental agentsmay modulate the functions of genes and the increase risk for pulmonary disease.


2006 ◽  
Vol 13 (6) ◽  
pp. 327-335 ◽  
Author(s):  
Hans-Peter Hauber ◽  
Susan C Foley ◽  
Qutayba Hamid

Mucus overproduction and hypersecretion are commonly observed in chronic inflammatory lung disease. Mucins are gel-forming glycoproteins that can be stimulated by a variety of mediators. The present review addresses the mechanisms involved in the upregulation of secreted mucins. Mucin induction by neutrophil elastase, bacteria, cytokines, growth factors, smoke and cystic fibrosis transmembrane conductance regulator malfunction are also discussed.


Sign in / Sign up

Export Citation Format

Share Document